Amphastar Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $1.58B
Liabilities Breakdown FY2024
Total Liabilities: $845.2M
Asset Breakdown
Total Assets: $1.58B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $151.6M | 9.6% |
| Accounts Receivable | $136.3M | 8.6% |
| Inventory | $153.7M | 9.7% |
| Property, Plant & Equipment | $297.3M | 18.8% |
| Goodwill | $3.0M | 0.2% |
| Intangible Assets | $558.4M | 35.4% |
| Other Assets | $277.1M | 17.6% |
Liabilities Breakdown
Total Liabilities: $845.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $30.5M | 3.6% |
| Long-Term Debt | $613.5M | 72.6% |
| Other Liabilities | $201.1M | 23.8% |